Explore the full record of transactions filed by McGrath Yvonne, Vice-Présidente, Recherche et Développement et Directrice Scientifique. Director active across 2 companies, notably iTeos Therapeutics, Inc.. In total, 11 filings have been logged. The latest transaction was filed on 1 March 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Yvonne McGrath is VP, Research and Development and Chief Scientific Officer at iTeos Therapeutics, Inc. In this role, she oversees the company's research and development initiatives, ensuring innovation and advancement of scientific projects. Her expertise is essential to support the organization's mission.